About BioPhenoMA
BioPhenoMA is a company based in Shinjuku (Japan) founded in 2023 by Etsuro Ito and Naoto Fujii.. BioPhenoMA has raised $1.23 million across 1 funding round from investors including WUV and JMTC. BioPhenoMA operates in a competitive market with competitors including Lunaphore, Parallel Fluidics, CellFE, Sarcura and Lightcast Discovery, among others.
- Headquarter Shinjuku, Japan
- Founders Etsuro Ito, Naoto Fujii
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.23 M (USD)
in 1 rounds
-
Latest Funding Round
$1.23 M (USD), Seed
Nov 07, 2024
-
Investors
WUV
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BioPhenoMA
BioPhenoMA has successfully raised a total of $1.23M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.23 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.2M
-
First Round
First Round
(07 Nov 2024)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Seed - BioPhenoMA | Valuation | WUV , JMTC |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioPhenoMA
BioPhenoMA has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include WUV and JMTC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Startups across sectors are accelerated by corporate-backed programs at JMTC.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioPhenoMA
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioPhenoMA
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biophenoma Comparisons
Competitors of BioPhenoMA
BioPhenoMA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lunaphore, Parallel Fluidics, CellFE, Sarcura and Lightcast Discovery, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Microfluidic-based instruments for tumor analysis are developed.
|
|
| domain | founded_year | HQ Location |
Microfluidic chips are provided for research labs using embossing technology.
|
|
| domain | founded_year | HQ Location |
Intracellular gene delivery platform is developed using microfluidic devices.
|
|
| domain | founded_year | HQ Location |
Cell therapy solutions for multiple therapeutic areas are developed.
|
|
| domain | founded_year | HQ Location |
Advanced single-cell analysis solutions are provided for biotechnology research.
|
|
| domain | founded_year | HQ Location |
Manufacturer of microfluidic chips
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biophenoma
Frequently Asked Questions about BioPhenoMA
When was BioPhenoMA founded?
BioPhenoMA was founded in 2023 and raised its 1st funding round 1 year after it was founded.
Where is BioPhenoMA located?
BioPhenoMA is headquartered in Shinjuku, Japan. It is registered at Shinjuku, Tokyo, Japan.
Who is the current CEO of BioPhenoMA?
Naoto Fujii is the current CEO of BioPhenoMA. They have also founded this company.
Is BioPhenoMA a funded company?
BioPhenoMA is a funded company, having raised a total of $1.23M across 1 funding round to date. The company's 1st funding round was a Seed of $1.23M, raised on Nov 07, 2024.
What does BioPhenoMA do?
Developer of microfluidic devices for the detection of ultra-trace proteins. The company is working on the development of a compact benchtop detection system using microfluidic device that can detect ultra-trace proteins by utilizing the TN-cyclon(improved enzymatic cycling method).
Who are the top competitors of BioPhenoMA?
BioPhenoMA's top competitors include CellFE, Parallel Fluidics and Lightcast Discovery.
Who are BioPhenoMA's investors?
BioPhenoMA has 2 investors. Key investors include WUV, and JMTC.